Allarity Therapeutics Files 8-K
Ticker: ALLR · Form: 8-K · Filed: Feb 27, 2025 · CIK: 1860657
Sentiment: neutral
Topics: corporate-event, filing
Related Tickers: ALLR
TL;DR
ALLARITY THERAPEUTICS (ALLR) FILED AN 8-K ON 2/27/25 FOR EVENTS ON 2/26/25.
AI Summary
Allarity Therapeutics, Inc. filed an 8-K on February 27, 2025, reporting an event on February 26, 2025. The filing is primarily for "Other Events" and "Financial Statements and Exhibits." The company is incorporated in Delaware and its principal executive offices are located in Boston, MA.
Why It Matters
This 8-K filing indicates a corporate event or update from Allarity Therapeutics, Inc., requiring disclosure to investors.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not inherently present new risks.
Key Players & Entities
- Allarity Therapeutics, Inc. (company) — Registrant
- February 26, 2025 (date) — Date of earliest event reported
- February 27, 2025 (date) — Filing Date
- Boston, MA (location) — Principal executive offices
FAQ
What specific event triggered this 8-K filing?
The filing indicates 'Other Events' and 'Financial Statements and Exhibits' as the items being reported, but does not specify the exact event in the provided text.
When was the earliest event reported in this filing?
The earliest event reported was on February 26, 2025.
What is the filing date of this 8-K?
The 8-K was filed on February 27, 2025.
Where are Allarity Therapeutics, Inc.'s principal executive offices located?
The principal executive offices are located at 24 School Street, 2nd Floor, Boston, MA 02108.
What is the SEC file number for Allarity Therapeutics, Inc.?
The SEC file number is 001-41160.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 27, 2025 regarding Allarity Therapeutics, Inc. (ALLR).